Biogen (BIIB) EBT (2009 - 2026)
Biogen (BIIB) posted quarterly EBT of $132.4 million for Q2 2026, down 82.2% year-over-year from $744.0 million in Q2 2025, and down 64.95% quarter-over-quarter from $377.7 million in Q1 2026.
Biogen (BIIB) EBT (2009 - 2026) Analysis & Trends
Biogen's EBT history runs 18 years deep, the most recent figure standing at $132.4 million for Q2 2026.
- In Q2 2026, EBT fell 82.2% year-over-year to $132.4 million; the TTM figure through Jun 2026 stood at $1.0 billion (down 43.74% YoY), while the FY2025 annual figure was $1.6 billion, down 18.34% from the prior year.
- EBT for Q2 2026 stood at $132.4 million, down from $377.7 million in the prior quarter.
- The five-year high for EBT was $1.4 billion in Q3 2022, with the low at -$141.2 million in Q3 2023.
- The 5-year median for EBT is $444.6 million (2023), against an average of $492.3 million.
- The sharpest annual moves came in 2024 and 2025: EBT soared 419.41% in 2024, then plunged 119.21% in 2025.
- Biogen's EBT stood at $603.8 million in 2022, then tumbled by 51.71% to $291.6 million in 2023, then fell by 0.03% to $291.5 million in 2024, then tumbled by 119.21% to -$56.0 million in 2025, then jumped by 336.43% to $132.4 million in 2026.
- Business Quant data shows BIIB's EBT at $132.4 million in Q2 2026, $377.7 million in Q1 2026, and -$56.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 648.58 Bn | 627.82 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 466.01 Bn | 459.44 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 375.19 Bn | 368.05 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 300.09 Bn | 292.40 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 256.64 Bn | 251.74 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 235.38 Bn | 221.39 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 180.78 Bn | 177.60 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 159.94 Bn | 148.24 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Gsk | 105.22 Bn | 101.06 Bn | 8.24 Bn | 474.95 Mn |
| 10 | Biogen | 31.86 Bn | 30.58 Bn | 1.96 Bn | 132.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 132.40 Mn |
| Mar 31, 2026 | 377.70 Mn |
| Dec 31, 2025 | -56.00 Mn |
| Sep 30, 2025 | 557.30 Mn |
| Jun 30, 2025 | 744.00 Mn |
| Mar 31, 2025 | 311.20 Mn |
| Dec 31, 2024 | 291.50 Mn |
| Sep 30, 2024 | 451.00 Mn |
| Jun 30, 2024 | 698.70 Mn |
| Mar 31, 2024 | 464.80 Mn |
| Dec 31, 2023 | 291.60 Mn |
| Sep 30, 2023 | -141.20 Mn |
| Jun 30, 2023 | 708.10 Mn |
| Mar 31, 2023 | 438.30 Mn |
| Dec 31, 2022 | 603.80 Mn |
| Sep 30, 2022 | 1.37 Bn |
| Jun 30, 2022 | 1.27 Bn |
| Mar 31, 2022 | 347.40 Mn |
| Dec 31, 2021 | 405.00 Mn |
| Sep 30, 2021 | 291.10 Mn |